With respect to neoplastic diseases, acute myeloid leukemia (AML), and cervical cancer were also associated with TLR9 genetic variants (105–107), while rs187084 is proposed to be a prognostic factor in patients with prostate cancer (108). Here, TLR9 is linked to acute myeloid leukemia.